The company’s revenue increased 16.4% year-on-year to ₹411 crore, compared with ₹353 crore in the same period last year.
At the operating level, earnings before interest, taxes, depreciation and amortisation (EBITDA) rose 1.1% to ₹79.3 crore from ₹78.4 crore a year earlier. The EBITDA margin declined to 19.3% from 22.2% in the year-ago period.
ALSO READ | Jupiter Life Line sees occupancy ramp-up and new hospitals driving FY27 growth
The company also announced that Jupiter Hospital Pharmacy Private Ltd (JHPPL), a subsidiary of Jupiter Life, has acquired 100% equity share capital of Sulcus Private Ltd for a consideration of ₹3.78 crore. Following the acquisition, Sulcus has become a wholly owned subsidiary of JHPPL and a step-down subsidiary of Jupiter Life.
The acquisition constitutes a related party transaction as Sulcus shares were acquired from Ankit Thakker and Kirtika Thakker, members of the promoter and promoter group. The company said the acquisition was undertaken on an arm’s length basis following an independent valuation.
Jupiter Life has appointed Harshad Purani as the Chief Financial Officer (CFO) and Key Managerial Personnel of the company, effective July 31, 2026. Purani has been associated with the company since September 2007 and has more than 20 years of experience.
ALSO READ | Jupiter Life Line Hospitals sees ARPOB rising in line with inflation
Dr Ankit Thakker, MD and CEO, said, “Our Dombivli hospital completed its first full quarter of operations; occupancy has been increasing steadily, supported by increasing patient footfall, expansion of clinical services and growing patient acceptance. The EBITDA loss from Dombivli of 9.5 crore in this quarter is in line with internal projections and earlier guidance.
We have also initiated the process of insurance empanelment, which is expected to further improve patient inflows in the coming quarters. In line with our phased development strategy, we continue to add new specialties, strengthen our consultant base and expand service offerings to support a steady ramp-up.
Pune South, Mira Road and BKC projects are continuing to progress as discussed earlier. Our established hospitals continue to maintain healthy occupancy levels, providing a stable financial and operational base.”
ALSO READ | Jupiter Life Line sees rising occupancy, gears up for new hospital projects
Shares of Jupiter Life Line Hospitals Ltd ended at ₹327.75, down by ₹4.55, or 1.37%, on the BSE.
